MIRA INFORM REPORT

 

 

Report No. :

319498

Report Date :

25.04.2015

 

IDENTIFICATION DETAILS

 

Name :

HETERO LABS LIMITED (W.e.f. 30.05.1997)

 

 

Formerly Known As:

PHARMASIA LABORATORIES PRIVATE LIMITED (w.e.f. 30.12.1992)

 

PERMILA DRUGS PRIVATE LIMITED

 

 

Registered Office :

7-2-A2, Hetero Corporate Industrial Estate, Sanathnagar, Hyderabad – 500018, Telangana

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

10.03.1989

 

 

Com. Reg. No.:

01-009723

 

 

Capital Investment / Paid-up Capital :

Rs. 13.320 Millions

 

 

CIN No.:

[Company Identification No.]

U24110TG1989PLC009723

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

Not Available

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Active Pharmaceutical Ingredients (APIs) and Finished Dosages

 

 

No. of Employees :

Not Divulged  (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (64)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 43000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Exist

 

 

Comments :

Subject is a well – established company having fine track record.

 

The rating reflects company’s healthy financial risk profile marked by adequate liquidity position and decent profitability margins of the company.

 

Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitment.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 31, 2014

 

Country Name

Previous Rating

(30.09.2014)

Current Rating

(31.12.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long Term Bank Facility = A +

Rating Explanation

Adequate degree of safety and low credit risk.

Date

03.12.2014

 

 

Rating Agency Name

CARE

Rating

Short Term Bank Facility = A1

Rating Explanation

Very Strong degree of safety and low credit risk.

Date

03.12.2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION DENIED BY

 

Name :

Mr. Vijay Kumar

Designation :

Accountant Department

Contact No.:

91-40-23704924

Date :

14.02.2014

 

 

LOCATIONS

 

Registered Office :

7-2-A2, Hetero Corporate Industrial Estate, Sanathnagar, Hyderabad – 500018, Telangana

Tel. No.:

91-40-23704924

Fax No.:

91-40-23704924

E-Mail :

contact@heterodrugs.com

ramu@heterodrugs.com

vasucs@heterodrugs.com

sambhram.p@heterodrugs.com

Website :

http://www.heterodrugs.com

Area :

3000 Sq. ft.

Location :

Owned

 

 

Regional Office :

‘Hetero Drugs Limited’ 607/608, 6th Floor, Matharu Arcade, Subhash Road, Ville Parle (East), Mumbai – 400 057, Maharashtra, India

Tel. No.:

91-22-56910809

Fax No.:

91-22-26845709

 

 

Marketing Office:  :

Located at:

  • USA
  • Russia
  • Europe
  • China
  • Thailand
  • UAE
  • Egypt
  • South Africa

 

 

DIRECTORS

 

As on 31.03.2014

 

Name :

Dr. Bandi Partha Saradhi Reddy

Designation :

Managing Director

Address :

Plot No. 389, Road No. 22/B, Jublihills Chequepost, Madhapoor Road, Hyderabad – 500038, Andhra Pradesh, India

Date of Birth/Age :

06.03.1954

Qualification :

Ph.d in organic chemistry

Date of Appointment :

01.11.2011

DIN No.:

00015899

PAN No.:

AAJPB7067K

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U65993TG1993PTC015489

BANDIS INVESTMENTS PRIVATE LIMITED

Director

12/03/1993

12/03/1993

-

Active

NO

2

U24230TG1993PLC015582

HETERO DRUGS LIMITED

Managing director

01/04/2013

07/04/1993

-

Active

NO

3

U24110TG1989PLC009723

HETERO LABS LIMITED

Managing director

01/11/2011

05/12/1996

-

Active

NO

4

U72200TG1997PTC027306

HETERO MARBLES PRIVATE LIMITED

Director

12/06/1997

12/06/1997

-

Active

NO

5

U24239TG1990PLC012119

CIREX PHARMACEUTICALS LIMITED

Director

01/04/2000

01/04/2000

-

Active

NO

6

U24231TG1998PLC029961

SYMED LABS LIMITED

Director

31/03/2009

10/08/2000

-

Active

NO

7

U24239TG1995PLC020625

SAKETHA DRUGS AND INTERMEDIATES LIMITED

Director

18/04/2001

18/04/2001

-

Active

NO

8

U24239TG2002PLC040108

HETERO INTERNATIONAL LIMITED

Director

16/12/2002

16/12/2002

21/04/2011

Active

NO

9

U24239TG2004PLC043684

HETERO BIOTECH LIMITED

Director

19/07/2004

19/07/2004

29/06/2011

Active

NO

10

U24239TG2004PTC044633

INVAGEN PHARMACEUTICALS PRIVATE LIMITED

Director

17/11/2004

17/11/2004

-

Active

NO

11

U24230TG2004PTC044710

XIVA HEALLTH CARE PRIVATE LIMITED

Director

29/11/2004

29/11/2004

30/08/2011

Active

NO

12

U24239TG2005PTC046555

EXPICOR PHARMA PRIVATE LIMITED

Director

16/06/2005

16/06/2005

01/12/2010

Strike off

NO

13

U70102TG2005PTC048210

HETSYM ESTATES AND REALTORS PRIVATE LIMITED

Director

29/11/2005

29/11/2005

-

Active

NO

14

U45200TG2006PLC049668

HETERO INFRASTRUCTURE SEZ LIMITED

Director

31/03/2006

31/03/2006

-

Active

NO

15

U73100TG2007PTC052262

HETERO LIFE SCIENCES PRIVATE LIMITED

Director

05/01/2007

05/01/2007

-

Active

NO

16

U24239TG1996PLC025371

GENX PHARMA LIMITED

Director

26/09/2007

26/07/2007

-

Active

NO

17

U72900TG2007PLC055111

HETERO INFORMATION TECHNOLOGIES LIMITED

Director

10/08/2007

10/08/2007

-

Active

NO

18

U45400TG2007PTC055324

SRI AYYAPPA LAND HOLDINGS PRIVATE LIMITED

Director

30/08/2007

30/08/2007

-

Active

NO

19

U01119TG2007PTC055326

SRI SANKARANATH AGRITECH PRIVATE LIMITED

Director

30/08/2007

30/08/2007

-

Active

NO

20

U45400TG2007PTC055329

SAI SPURTHI LAND VENTURES PRIVATE LIMITED

Director

30/08/2007

30/08/2007

-

Active

NO

21

U45200TG2007PTC055523

SRI LORD VENKATESWARA LAND HOLDINGS PRIVATE LIMITED

Director

14/09/2007

14/09/2007

-

Active

NO

22

U01119TG2007PTC055650

RAJESWARI AGRO CHEMICALS PRIVATE LIMITED

Director

22/09/2007

22/09/2007

-

Active

NO

23

U40102TG2007PLC055910

HETERO MED SOLUTIONS LIMITED

Director

15/10/2007

15/10/2007

-

Active

NO

24

U74999TG2007PLC056072

SRI SAI ASHIRWAAD LOGISTICS LIMITED

Director

25/10/2007

25/10/2007

13/02/2014

Active

NO

25

U70102TG2008PTC057902

SHREE SHIVA SINDHU REAL ESTATES PRIVATE LIMITED

Director

28/02/2008

28/02/2008

-

Active

NO

26

U72200TG2008PTC057903

SRI SHIVA SHANKAR SOFT SERVICES PRIVATE LIMITED

Director

28/02/2008

28/02/2008

-

Active

NO

27

U01119TG2008PTC057982

LAKSHMI PRASANNA AGRI PRODUCTS PRIVATE LIMITED

Director

05/03/2008

05/03/2008

-

Active

NO

28

U74900TG2008PLC058017

SHRI BHRAMARAMBIKAS INDUSTRYS LIMITED

Director

06/03/2008

06/03/2008

-

Active

NO

29

U24299TG2008PLC058020

HETERO BIO CHEMICALS LIMITED

Director

06/03/2008

06/03/2008

29/06/2011

Active

NO

30

U70102TG2008PTC058106

SRI SHAKTI SWAROOPINI REALTORS PRIVATE LIMITED

Director

11/03/2008

11/03/2008

-

Active

NO

31

U73100TG2008PTC058109

HETSYM BIO CHEMICALS PRIVATE LIMITED

Director

11/03/2008

11/03/2008

-

Active

NO

32

U24110TG2008PTC058116

SYMED CHEMICALS PRIVATE LIMITED

Director

11/03/2008

11/03/2008

-

Active

NO

33

U45209TG2008PTC059000

SREE SAI KHYATHI INFRA VENTURES PRIVATE LIMITED

Director

05/05/2008

05/05/2008

-

Active

NO

34

U45200TG2008PTC059007

SHREE SAI LOK AVENUES PRIVATE LIMITED

Director

06/05/2008

06/05/2008

-

Active

NO

35

U52520TG2006PLC049614

HETERO HEALTHCARE LIMITED

Director

24/09/2009

01/10/2008

-

Active

NO

36

U24230TG1984PTC004422

SVS DRUGS AND PHARMACEUTICALS PVT LTD

Director

19/08/2010

12/11/2009

-

Active

NO

37

U40100TG2010PLC071837

HETERO WIND POWER LIMITED

Director

23/12/2010

23/12/2010

-

Active

NO

38

U24232TG2011PLC074274

SRI SAI KARUNA INDUSTRYS LIMITED

Director

04/05/2011

04/05/2011

-

Active

NO

39

U24233TG2011PLC077561

HONOUR LAB LIMITED

Director

21/11/2011

21/11/2011

-

Active

NO

40

U45400TG2012PLC083644

HONOUR INFRA ESTATES LIMITED

Director

17/10/2012

17/10/2012

-

Active

NO

41

U24100TG2014PLC092771

ASPIRO PHARMA LIMITED

Director

25/09/2014

13/02/2014

-

Active

NO

 

 

Name :

Mr. Srinivas Reddy Male

Designation :

Whole-time Director

Address :

Plot No.933, Vivrkanandnagar, Kukatpally, Hyderabad- 500 072, Andhra Pradesh, India

Date of Birth/Age :

02.02.1973

Qualification :

MBA. Marketing

Date of Appointment :

01.08.2013

DIN No.:

00016085

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U45200TG1995PTC021532

VIPASSANA CONSTRUCTIONS PRIVATE LIMITED

Director

01/04/1997

01/04/1997

-

Active

NO

2

U24239TG1996PLC025371

GENX PHARMA LIMITED

Director

31/07/2008

28/10/1999

-

Active

NO

3

U24230TG1993PLC015582

HETERO DRUGS LIMITED

Director

29/09/2011

01/04/2001

-

Active

NO

4

U65993TG1993PTC015489

BANDIS INVESTMENTS PRIVATE LIMITED

Director

01/11/2001

01/11/2001

-

Active

NO

5

U24239TG1995PLC020625

SAKETHA DRUGS AND INTERMEDIATES LIMITED

Director

01/04/2002

01/04/2002

29/06/2011

Active

NO

6

U24239TG2002PLC040108

HETERO INTERNATIONAL LIMITED

Director

16/12/2002

16/12/2002

29/06/2011

Active

NO

7

U24239TG2004PLC043684

HETERO BIOTECH LIMITED

Director

19/07/2004

19/07/2004

01/12/2010

Active

NO

8

U85110TG1989PTC010293

HYDERABAD HOSPITALS PVT. LTD.

Director

29/09/2004

29/09/2004

-

Active

NO

9

U24230TG2004PTC044710

XIVA HEALLTH CARE PRIVATE LIMITED

Director

29/11/2004

29/11/2004

-

Active

NO

10

U52520TG2006PLC049614

HETERO HEALTHCARE LIMITED

Director

24/03/2006

24/03/2006

-

Active

NO

11

U73100TG2007PTC052262

HETERO LIFE SCIENCES PRIVATE LIMITED

Director

05/01/2007

05/01/2007

-

Active

NO

12

U24231TG1998PLC029961

SYMED LABS LIMITED

Director

06/09/2007

11/07/2007

26/09/2014

Active

NO

13

U72900TG2007PLC055111

HETERO INFORMATION TECHNOLOGIES LIMITED

Director

10/08/2007

10/08/2007

29/06/2011

Active

NO

14

U40102TG2007PLC055910

HETERO MED SOLUTIONS LIMITED

Director

15/10/2007

15/10/2007

-

Active

NO

15

U74999TG2007PLC056072

SRI SAI ASHIRWAAD LOGISTICS LIMITED

Director

25/10/2007

25/10/2007

08/03/2012

Active

NO

16

U24299TG2008PLC058020

HETERO BIO CHEMICALS LIMITED

Director

06/03/2008

06/03/2008

21/04/2011

Active

NO

17

U24230TG1984PTC004422

SVS DRUGS AND PHARMACEUTICALS PVT LTD

Director

01/08/2008

01/08/2008

-

Active

NO

18

U24110TG1989PLC009723

HETERO LABS LIMITED

Whole-time director

01/08/2013

01/08/2008

-

Active

NO

19

U45200TG2006PLC049668

HETERO INFRASTRUCTURE SEZ LIMITED

Director

18/09/2008

01/08/2008

29/09/2014

Active

NO

20

U72200TG1997PTC027306

HETERO MARBLES PRIVATE LIMITED

Director

12/11/2009

12/11/2009

-

Active

NO

21

U24239TG1990PLC012119

CIREX PHARMACEUTICALS LIMITED

Director

26/08/2010

12/11/2009

-

Active

NO

22

U21023TG2007PTC054088

CHEMI PACK (INDIA) PRIVATE LIMITED

Director

19/08/2010

19/11/2009

08/03/2012

Active

NO

23

U40100TG2010PLC071837

HETERO WIND POWER LIMITED

Director

23/12/2010

23/12/2010

-

Active

NO

24

U74900TG2008PLC058017

SHRI BHRAMARAMBIKAS INDUSTRYS LIMITED

Director

07/04/2011

07/04/2011

-

Active

NO

25

U24232TG2011PLC074274

SRI SAI KARUNA INDUSTRYS LIMITED

Director

04/05/2011

04/05/2011

-

Active

NO

26

U24233TG2011PLC077561

HONOUR LAB LIMITED

Director

21/11/2011

21/11/2011

-

Active

NO

27

U45400TG2012PLC083644

HONOUR INFRA ESTATES LIMITED

Director

17/10/2012

17/10/2012

11/09/2014

Active

NO

28

U24100TG2014PLC092771

ASPIRO PHARMA LIMITED

Additional director

13/02/2014

13/02/2014

25/09/2014

Active

NO

29

U24233TG2014PTC096797

AZISTA PHARMACEUTICALS PRIVATE LIMITED

Director

11/12/2014

11/12/2014

-

Active

NO

Name :

Mr. Vamsikrishna Bandi

Designation :

Whole-time director

Address :

Plot No.389, Road No.22/B, Jubilee Hills, Check-Post, Hyderabad-500 033, Andhra Pradesh, India

Date of Birth/Age :

31.07.1983

Date of Appointment :

01.05.2011

DIN No.:

01014619

PAN No.:

AIPPB1881R

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230TG2004PTC044710

XIVA HEALLTH CARE PRIVATE LIMITED

Director

29/11/2004

29/11/2004

-

Active

NO

2

U73100TG2007PTC052262

HETERO LIFE SCIENCES PRIVATE LIMITED

Director

05/01/2007

05/01/2007

-

Active

NO

3

U24239TG1996PLC025371

GENX PHARMA LIMITED

Director

26/09/2007

26/07/2007

-

Active

NO

4

U40102TG2007PLC055910

HETERO MED SOLUTIONS LIMITED

Director

15/10/2007

15/10/2007

-

Active

NO

5

U74999TG2007PLC056072

SRI SAI ASHIRWAAD LOGISTICS LIMITED

Director

25/10/2007

25/10/2007

-

Active

NO

6

U24299TG2008PLC058020

HETERO BIO CHEMICALS LIMITED

Director

06/03/2008

06/03/2008

-

Active

NO

7

U65993TG1993PTC015489

BANDIS INVESTMENTS PRIVATE LIMITED

Additional director

10/04/2008

10/04/2008

-

Active

NO

8

U24230TG1993PLC015582

HETERO DRUGS LIMITED

Director

25/09/2008

10/04/2008

-

Active

NO

9

U52520TG2006PLC049614

HETERO HEALTHCARE LIMITED

Director

25/09/2008

10/04/2008

-

Active

NO

10

U24239TG1990PLC012119

CIREX PHARMACEUTICALS LIMITED

Director

29/09/2011

10/04/2008

-

Active

NO

11

U24110TG1989PLC009723

HETERO LABS LIMITED

Whole-time director

01/05/2011

10/04/2008

-

Active

NO

12

U24231TG1998PLC029961

SYMED LABS LIMITED

Director

01/04/2012

10/04/2008

-

Active

NO

13

U72200TG1997PTC027306

HETERO MARBLES PRIVATE LIMITED

Director

12/11/2009

12/11/2009

-

Active

NO

14

U24230TG1984PTC004422

SVS DRUGS AND PHARMACEUTICALS PVT LTD

Director

19/08/2010

12/11/2009

-

Active

NO

15

U72900TG2007PLC055111

HETERO INFORMATION TECHNOLOGIES LIMITED

Director

30/09/2010

12/11/2009

21/04/2011

Active

NO

16

U24239TG2004PLC043684

HETERO BIOTECH LIMITED

Director

19/08/2010

12/11/2009

29/06/2011

Active

NO

17

U24239TG1995PLC020625

SAKETHA DRUGS AND INTERMEDIATES LIMITED

Director

19/08/2010

12/11/2009

29/06/2011

Active

NO

18

U21023TG2007PTC054088

CHEMI PACK (INDIA) PRIVATE LIMITED

Director

19/08/2010

19/11/2009

06/02/2014

Active

NO

19

U45200TG2006PLC049668

HETERO INFRASTRUCTURE SEZ LIMITED

Director

23/09/2010

02/08/2010

-

Active

NO

20

U40100TG2010PLC071837

HETERO WIND POWER LIMITED

Director

23/12/2010

23/12/2010

-

Active

NO

21

U74900TG2008PLC058017

SHRI BHRAMARAMBIKAS INDUSTRYS LIMITED

Director

07/04/2011

07/04/2011

-

Active

NO

22

U24232TG2011PLC074274

SRI SAI KARUNA INDUSTRYS LIMITED

Director

04/05/2011

04/05/2011

-

Active

NO

23

U24233TG2011PLC077561

HONOUR LAB LIMITED

Director

21/11/2011

21/11/2011

-

Active

NO

24

U45400TG2012PLC083644

HONOUR INFRA ESTATES LIMITED

Director

17/10/2012

17/10/2012

-

Active

NO

25

U24100TG2014PLC092771

ASPIRO PHARMA LIMITED

Director

25/09/2014

13/02/2014

-

Active

NO

 

Name :

Mr. Attunuri Venkata Narasa Reddy

Designation :

Whole Time Director

Address :

H. No. 8-3-678/61, Pragathi Nagar Colony, Yosufguda, Hyderabad – 500018, Andhra Pradesh, India

Date of Birth/Age :

21.12.1963

Date of Appointment :

11.03.1999

DIN No.:

00023432

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230TG1993PLC015582

HETERO DRUGS LIMITED

Director

28/01/1999

28/01/1999

-

Active

NO

2

U24110TG1989PLC009723

HETERO LABS LIMITED

Whole-time director

02/06/2014

11/03/1999

-

Active

NO

3

U24239TG2004PLC043684

HETERO BIOTECH LIMITED

Director

19/07/2004

19/07/2004

-

Active

NO

4

U24239TG2004PTC044633

INVAGEN PHARMACEUTICALS PRIVATE LIMITED

Director

17/11/2004

17/11/2004

-

Active

NO

5

U24239TG2005PTC046555

EXPICOR PHARMA PRIVATE LIMITED

Director

16/06/2005

16/06/2005

-

Strike off

NO

6

U52520TG2006PLC049614

HETERO HEALTHCARE LIMITED

Director

24/03/2006

24/03/2006

25/09/2008

Active

NO

7

U72900TG2007PLC055111

HETERO INFORMATION TECHNOLOGIES LIMITED

Director

10/08/2007

10/08/2007

30/09/2010

Active

NO

Name :

Mr. Mohan Reddy Chilukuri

Designation :

Whole Time Director

Address :

Plot No.54, Green Avenue, Nizampet Road, Nizampet, Hyderabad – 500000, Andhra Pradesh, India

Date of Birth/Age :

02.01.1969

Date of Appointment :

01.04.2012

DIN No.:

00208921

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24110TG1989PLC009723

HETERO LABS LIMITED

Whole-time director

01/04/2012

18/11/1999

-

Active

NO

                                 

 

KEY EXECUTIVES

 

Name :

Mr. Vijay Kumar

Designation :

Accountant Department

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 31.03.2014

 

Names of Shareholders

No. of Shares

%age

B. Partha Saradhi Reddy

282860

21.24

B. Kalavathi

160740

12.07

M. Krishna Sindhuri

150000

11.26

B. Vamsi Krishna

398000

29.88

M. Srinivas Reddy

200

0.02

B. Srinivasula Reddy

200

0.02

B. Soma Kantham

200

0.02

M. Krishna Karthikeya Reddy

146900

11.03

B. Anvida

46000

3.45

M. Krishna Sahithi

146900

11.03

Total

1332000

100.00

 

 

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Active Pharmaceutical Ingredients (APIs) and Finished Dosages.

 

 

Products :

Product Description

Item Code No. (ITC Code)

Bulk Drugs and Drug Intermediates

294110

Pharmaceuticals Formulation

300410

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

Terms :

Not Divulged

 

 

GENERAL INFORMATION

 

Suppliers :

Not Divulged

 

 

Customers :

Not Divulged

 

 

No. of Employees :

Not Divulged 

 

 

Bankers :

Banker Name

Bank Of India

Branch Address

Hyderabad Large Corporate Branch, 10-1-1199/2, 1st Floor, P.T.I. Building, A.C.Guards, Masab Tank, Hyderabad – 500004, Andhra Pradesh, India

Person Name (With Designation)

Not Divulged 

Contact Number

Not Divulged 

Name of Account Holder

Not Divulged 

Account Number

Not Divulged 

Account Since (Date/Year of Account Opening)

Not Divulged 

Average Balance Maintained (If Possible)

Not Divulged 

Credit Facilities Enjoyed (If any)

Not Divulged 

Account Operation

Not Divulged 

Remarks (If any)

Not Divulged 

 

 

Facilities :

(Rs. In Millions)

SECURED LOAN

As on

31.03.2014

As on

31.03.2013

LONG TERM BORROWING

 

 

Rupee From Loans From Bank

2015.957

1452.051

Foreign Currency Term Loans From Bank

1515.567

2107.542

SHORT TERM BORROWING

 

 

Working Capitals Loan From Bank

9394.383

8065.918

 

 

 

Total

12925.907

11625.511

 

Auditors :

 

Name :

M. V. Narayana Reddy and Company

Chartered Accountants

Address :

D. No. 8-3-941, Flat No. 504, Vijayasree Apartments, Opposite Kamma Sangham, Ameerpet, Hyderabad – 500073 Andhra Pradesh, India

Tel. No.:

91-40-23743975 / 23744448

PAN No.:

AADFM4830F

 

 

Memberships :

Not Available

 

 

Collaborators :

Not Available

 

 

Enterprises which are

owned, or have significant

influence of or are partners

with Key management

personnel and their relatives :

  • Cirex Pharmaceuticals Limited
  • Clinse Labs Private Limited
  • Genx Pharma Limited
  • Hetero Drugs Limited
  • Hetero Healthcare Limited
  • Symed Labs Limited
  • Chemi Pack (India) Private Limited
  • Hetero Med Solutions Limited
  • Camber Pharmaceuticals Inc
  • Invagen Pharmaceuticals Inc
  • Hetmak Fzco
  • Akar International Fzc
  • Mint Pharmaceuticals IncHonour Lab Limited

 

 

Subsidiary company

  • Hetero Fzco
  • Hetero Wind Power Limited

 

 

Joint venture

Pharmed Healthcare

Fellow Subsidiary company

HETLABS MEXICO

 

 

Associate :

  • Hetero Infrastructure Sez Limited
  • Hetero (Thailand) Limited
  • Hetero Singapore Pte Limited
  • Hetero Usa Inc
  • Hetero Europe SL
  • Arapharma Group S A

 

 

CAPITAL STRUCTURE

 

As on 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1500000

Equity Shares

Rs.10/- each

Rs.15.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

132000

Equity Shares

Rs.10/- each

Rs.13.320 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

13.320

13.320

13.320

(b) Reserves & Surplus

15193.981

11449.970

9651.664

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

15207.301

11463.290

9664.984

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

3531.524

3559.593

2768.186

(b) Deferred tax liabilities (Net)

1199.897

1071.107

735.668

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

95.243

74.408

49.947

Total Non-current Liabilities (3)

4826.664

4705.108

3553.801

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

10090.177

9435.509

7778.435

(b) Trade payables

4753.913

4808.864

3973.460

(c) Other current liabilities

3085.584

2563.013

1740.905

(d) Short-term provisions

126.594

110.383

78.292

Total Current Liabilities (4)

18056.268

16917.769

13571.092

 

 

 

 

TOTAL

38090.233

33086.167

26789.877

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

10448.326

9919.285

7789.060

(ii) Intangible Assets

68.965

17.902

21.693

(iii) Capital work-in-progress

2845.841

1477.437

2373.585

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

1004.939

888.107

391.607

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

922.041

1100.254

1019.898

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

15290.112

13402.985

11595.843

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

8998.963

9310.699

7382.000

(c) Trade receivables

11916.555

9287.242

6686.970

(d) Cash and cash equivalents

321.995

189.818

230.974

(e) Short-term loans and advances

638.051

57.225

68.188

(f) Other current assets

924.557

838.198

825.902

Total Current Assets

22800.121

19683.182

15194.034

 

 

 

 

TOTAL

38090.233

33086.167

26789.877

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

Income

37301.511

27605.375

20381.480

 

Other Income

752.562

291.542

47.902

 

 

TOTAL                                    

38054.073

27896.917

20429.382

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Cost of Materials Consumed

22096.168

14987.593

13605.379

 

Purchases of Stock-in-Trade

116.785

457.716

344.046

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

(262.222)

746.356

(1905.333)

 

Employees benefits expense

1975.151

1466.736

980.549

 

Other expenses

6886.758

5541.959

3786.144

 

 

TOTAL                                    

30812.640

23200.360

16810.785

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

7241.433

4696.557

3618.597

 

 

 

 

 

Less

FINANCIAL EXPENSES                                   

1683.453

1465.230

870.778

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

5557.980

3231.327

2747.819

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

585.846

524.330

398.001

 

 

 

 

 

 

PROFIT BEFORE TAX

4972.134

2706.997

2349.818

 

 

 

 

 

Less

TAX                                                                 

1198.262

878.713

749.832

 

 

 

 

 

 

PROFIT AFTER TAX

3773.872

1828.284

1599.986

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

193.990

105.660

66.630

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

3330.000

1710.000

1530.000

 

 

Dividend

29.860

29.980

30.960

 

 

Tax on Dividend

0.000

0.000

0.000

 

BALANCE CARRIED TO THE B/S

3773.872

1828.284

1599.986

 

 

 

 

 

 

Earnings Per Share (Rs.)

2833.24

1372.61

1201.19

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT/Sales)

(%)

10.12

6.62

7.85

 

 

 

 

 

Operating Profit Margin

(PBDIT / Sales)

(%)

19.41

17.01

17.75

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

14.52

8.81

9.78

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.33

0.24

0.24

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.90

1.13

1.09

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.26

1.16

1.12

 

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

13.320

13.320

13.320

Reserves & Surplus

9651.664

11449.970

15193.981

Net worth

9664.984

11463.290

15207.301

 

 

 

 

long-term borrowings

2768.186

3559.593

3531.524

Short term borrowings

7778.435

9435.509

10090.177

Total borrowings

10546.621

12995.102

13621.701

Debt/Equity ratio

1.091

1.134

0.896

 

 

 

 

YEAR-ON-YEAR GROWTH

 

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

20381.480

27605.375

37301.511

 

 

35.443

35.124

 

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

20381.480

27605.375

37301.511

Profit

1599.986

1828.284

3773.872

 

7.85%

6.62%

10.12%

 

 


 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

Yes

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

----------------------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

----------------------

22]

Litigations that the firm / promoter involved in

Yes

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------------------

26]

Buyer visit details

----------------------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

LITIGATION DETAILS

 

ITTA 356 / 2014

ITTASR 2161 / 2014

Case Status : Pending

PETTIONER

THE COMMISIONER OF INCOME TAX (CENTRAL)

RESPONDENT

VS HETERO LABS LIMITED

Pet’s Adv:-

PRASAD (SC FOR INCOME TAX)

Resp. Adv.:

HARI

SUBJECT :

U/Sec. 143 Assessment

DISTRICT

HYDERABAD

FILLING DATE :

31.05.2014

POSTING STAGE :

FOR ADMISSION AND HEARING

REG. DATE

06.06.2014

LISTING DATE

12.06.2014

STATUS

ADMIT

HON’BLE JUDGE (S)

SANJAY KUMAR

 

NOTE : Registered office of the company has been shifted from H .NO. 8-3-166/1 AND 2 Challa Estates, First Floor, Erragadda, Hyderabad – 500018, Andhra Pradesh, India to the present address (w.e.f 31.07.2009)

 

UNSECURED LOAN

 

                                                                                                                                                 (Rs. In Million)

Particulars

As on

31.03.2014

As on

31.03.2013

SHORT TERM BORROWING

 

 

Loans Repayable On Demand From Bank

695.794

1369.591

Total

695.794

1369.591

 

REVIEW OF PERFORMANCE :

 

The Company's APIs business increased to Rs 9638.810 Million. During the fiscal, compared to Rs9357.540 Million. During 2012-13 registering a growth of 3.01%. API Segment Exports increased to Rs.5148.11 Million. As compared to Rs.4306.21 Million. In the previous year registering an export growth of 20%.

 

The Company's formulation business increased to Rs. 28166.52 Million. During the fiscal, compared to Rs. 18712.25 Million. During 2012-13.

Formulation revenues were higher by 50.19% over the previous year on account of increase in formulation operations. Formulation Segment Exports increased to Rs20792.28 Million. As compared to Rs.13432.06 Million. In the previous year registering an export growth of 35.4%

 

 

FINANCE

 

The Company incurred finance cost of Rs.1812.390 Million during the year which is 24% higher than the previous year on account of increase in volume of operations and costs as well as higher cost of borrowings together with depreciation of rupee against major currencies.

 

The Company has repaid term loans of Rs.1146.100 Million during the year and availed fresh term loans of Rs.1261.100 Million to part finance capital expenditure during the year. The total term loans of the Company stood at Rs.5049.070 Million as on March 31, 2014.

 

 

OUTLOOK

 

Hetero during the past 4 years has developed assets for growth. People, products, Infrastructure and improved relationship with some of the big pharma Companies across the globe are the key drivers for growth of the Company. The Company is perceived as preferred and reliable supplier by its customers.

 

 The order flow remains encouraging and is being met with improved manufacturing efficiencies of pharmaceutical formulations, intermediates and Active Pharmaceuticals ingredients through process improvement and development.

 

Hetero is working to improve manufacturing process, optimize costs, reduce waste and operational expenditure, increase cash flow, rationalize manpower, protect margins, report positive earnings and risk the business.

 

INDEX OF CHARGES

 

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10478286

21/01/2014

2,126,200,000.00

BANK OF INDIA

Hyderabad Large Corporate Branch,10-1-1199/2,, 1s 
t Floor,P.T.I.Building, A.C.Guards, Masab Tank,, H 
yderabad, Andhra Pradesh - 500004, INDIA

B96678909

2

10467942

19/12/2013

1,200,000,000.00

EXPORT-IMPORT BANK OF INDIA

Centre One Building, Floor 21,, World Trade Centr 
e Complex, Cuffe Parade,, Mumbai, Maharashtra - 40 
0005, INDIA

B92651371

3

10461509

28/10/2013

1,257,000,000.00

DBS Bank Limited

Salarpuria Windsor, No.3, Ulsoor Road, Bengaluru, 
Karnataka - 560042, INDIA

B90049834

4

10421516

26/12/2013 *

4,186,400,000.00

State Bank of India

Industrial Finance Branch,, Rajbhavan Road, Somaj 
iguda, Hyderabad, Andhra Pradesh - 500082, INDIA

B94525177

5

10308989

14/09/2011

250,000,000.00

STATE BANK OF MYSORE

INDUSTRIAL FINANCE BRANCH, MY HOME JUPALLY, AMEER 
PET, HYDERABAD, Andhra Pradesh - 500038, INDIA

B22035851

6

10283954

28/09/2013 *

9,315,000,000.00

ANDHRA BANK

Specialized Corporate Finance Branch, 6-3-648,3rd 
Floor,Padmaja Land Mark, Somajiguda, Hyderabad, A 
ndhra Pradesh - 500082, INDIA

B87173050

7

10283970

26/03/2011

500,000,000.00

ANDHRA BANK

Specialised Corporate Finance Branch, 3rd Floor, 
Padmaja Land Mark, Hyderabad, Andhra Pradesh - 500 
082, INDIA

B12030003

8

10273568

29/12/2011 *

1,000,000,000.00

EXPORT-IMPORT BANK OF INDIA

CENTRE ONE BUILDING, FLOOR 21,, WORLD TRADE CENTR 
E, CUFFE PARADE, MUMBAI, Maharashtra - 400005, IND 
IA

B28834844

9

10257057

07/12/2010

500,000,000.00

ANDHRA BANK

SPECIALISED CORPORATE FINANCE BRANCH, 3rd FLOOR, 
PADMAJA LAND MARK, SOMAJIGUDA, HYDERABAD, Andhra P 
radesh - 500082, INDIA

B01508654

10

10257800

16/11/2010

500,000,000.00

STATE BANK OF HYDERBAD

SANATHNAGAR BRANCH, INDUSTRIAL ESTATE, SANATHNAGA 
R, HYDERABAD, Andhra Pradesh - 500018, INDIA

B00572214

 

FIXED ASSETS

 

  • Land and Site Development
  • Factory Building
  • Electrical Equipment
  • R and D Equipment
  • ETP Machinery
  • Furniture and Fixture
  • Office Equipments
  • Vehicles
  • Computers  

 

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.63.40

UK Pound

1

Rs.95.42

Euro

1

Rs.68.48

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

RNK


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

8

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILITY 

1~10

7

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

64

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.